Point72 Europe (London) LLP Bio Techne Corp Transaction History
Point72 Europe (London) LLP
- $1.1 Billion
- Q2 2024
A detailed history of Point72 Europe (London) LLP transactions in Bio Techne Corp stock. As of the latest transaction made, Point72 Europe (London) LLP holds 65,961 shares of TECH stock, worth $5.11 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
65,961
Previous 57,261
15.19%
Holding current value
$5.11 Million
Previous $4.03 Million
17.27%
% of portfolio
0.43%
Previous 0.38%
Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
604Shares Held
153MCall Options Held
171KPut Options Held
56.9K-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.41 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.16 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.53MShares$660 Million0.07% of portfolio
-
State Street Corp Boston, MA6.3MShares$488 Million0.02% of portfolio
-
Bamco Inc New York, NY4.78MShares$370 Million1.0% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $3.04B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...